🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 27/01/1986 | 3,61 | 3,63 | 3,59 | 3,59 | +0,18% | 1,10% | 5.017.824 |
| 24/01/1986 | 3,62 | 3,62 | 3,57 | 3,59 | -0,64% | 1,65% | 4.451.904 |
| 23/01/1986 | 3,61 | 3,61 | 3,59 | 3,61 | +0,00% | 0,46% | 4.780.138 |
| 22/01/1986 | 3,64 | 3,64 | 3,60 | 3,61 | -0,82% | 1,09% | 4.859.366 |
| 21/01/1986 | 3,65 | 3,66 | 3,62 | 3,64 | -0,27% | 1,00% | 4.780.138 |
| 20/01/1986 | 3,65 | 3,67 | 3,64 | 3,65 | +0,55% | 0,91% | 4.433.040 |
| 17/01/1986 | 3,63 | 3,67 | 3,61 | 3,63 | -0,18% | 1,73% | 13.314.211 |
| 16/01/1986 | 3,63 | 3,64 | 3,56 | 3,64 | +0,37% | 2,19% | 11.518.358 |
| 15/01/1986 | 3,61 | 3,64 | 3,61 | 3,62 | +0,00% | 0,92% | 6.975.907 |
| 14/01/1986 | 3,63 | 3,63 | 3,60 | 3,62 | +0,00% | 0,82% | 5.353.603 |
| 13/01/1986 | 3,60 | 3,63 | 3,58 | 3,62 | +0,92% | 1,38% | 7.436.189 |
| 10/01/1986 | 3,64 | 3,64 | 3,57 | 3,59 | -0,73% | 1,82% | 11.431.584 |
| 09/01/1986 | 3,66 | 3,67 | 3,57 | 3,62 | -1,80% | 2,90% | 18.796.090 |
| 08/01/1986 | 3,76 | 3,77 | 3,68 | 3,68 | -1,77% | 2,47% | 7.334.323 |
| 07/01/1986 | 3,75 | 3,76 | 3,74 | 3,75 | +0,44% | 0,62% | 5.644.109 |
| 06/01/1986 | 3,74 | 3,75 | 3,72 | 3,73 | +0,27% | 0,80% | 7.507.872 |
| 03/01/1986 | 3,66 | 3,73 | 3,65 | 3,72 | +1,81% | 2,18% | 8.639.712 |
| 02/01/1986 | 3,63 | 3,66 | 3,62 | 3,66 | +0,73% | 0,91% | 8.635.939 |
| 31/12/1985 | 3,61 | 3,65 | 3,60 | 3,63 | +0,46% | 1,29% | 7.443.734 |
| 30/12/1985 | 3,60 | 3,62 | 3,59 | 3,61 | +0,55% | 0,64% | 4.700.909 |
| 27/12/1985 | 3,55 | 3,60 | 3,55 | 3,59 | +1,78% | 1,49% | 5.368.694 |
| 26/12/1985 | 3,51 | 3,54 | 3,51 | 3,53 | +0,66% | 0,76% | 3.304.973 |
| 24/12/1985 | 3,51 | 3,51 | 3,49 | 3,51 | -0,19% | 0,66% | 4.580.179 |
| 23/12/1985 | 3,57 | 3,57 | 3,51 | 3,52 | -1,58% | 1,76% | 4.942.368 |
| 20/12/1985 | 3,59 | 3,62 | 3,57 | 3,57 | -0,55% | 1,29% | 15.426.979 |
| 19/12/1985 | 3,56 | 3,60 | 3,56 | 3,59 | +0,65% | 1,21% | 5.779.930 |
| 18/12/1985 | 3,58 | 3,60 | 3,56 | 3,57 | -0,65% | 1,20% | 7.300.368 |
| 17/12/1985 | 3,64 | 3,64 | 3,59 | 3,59 | -1,00% | 1,36% | 7.243.776 |
| 16/12/1985 | 3,57 | 3,64 | 3,55 | 3,63 | +1,76% | 2,41% | 9.232.042 |
| 13/12/1985 | 3,55 | 3,57 | 3,53 | 3,57 | +1,13% | 1,12% | 6.711.811 |